ZA909663B - 3-(n-methyl-n-alkyl)-amino 2-methoxymethylene propan 1-ol derivatives,a preparation process of the same and therapeutical compositions containing them - Google Patents

3-(n-methyl-n-alkyl)-amino 2-methoxymethylene propan 1-ol derivatives,a preparation process of the same and therapeutical compositions containing them

Info

Publication number
ZA909663B
ZA909663B ZA909663A ZA909663A ZA909663B ZA 909663 B ZA909663 B ZA 909663B ZA 909663 A ZA909663 A ZA 909663A ZA 909663 A ZA909663 A ZA 909663A ZA 909663 B ZA909663 B ZA 909663B
Authority
ZA
South Africa
Prior art keywords
methoxymethylene
propan
derivatives
amino
alkyl
Prior art date
Application number
ZA909663A
Other languages
English (en)
Inventor
Pierre Braquet
Braquet Pierre
Colette Broquet
Broquet Colette
Benedicte Vandamme
Vandamme Benedicte
Paola Principe-Nicolas
Principe-Nicolas Paola
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of ZA909663B publication Critical patent/ZA909663B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/10—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with one amino group and at least two hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20—Quaternary compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
ZA909663A 1989-12-19 1990-11-30 3-(n-methyl-n-alkyl)-amino 2-methoxymethylene propan 1-ol derivatives,a preparation process of the same and therapeutical compositions containing them ZA909663B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898928580A GB8928580D0 (en) 1989-12-19 1989-12-19 3-(n-methyl-n-alkylamino)-methoxymethyl-propanol phosphocholine derivatives

Publications (1)

Publication Number Publication Date
ZA909663B true ZA909663B (en) 1991-09-25

Family

ID=10668132

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA909663A ZA909663B (en) 1989-12-19 1990-11-30 3-(n-methyl-n-alkyl)-amino 2-methoxymethylene propan 1-ol derivatives,a preparation process of the same and therapeutical compositions containing them

Country Status (32)

Country Link
US (1) US5118674A (fi)
JP (1) JPH04208256A (fi)
KR (1) KR910011759A (fi)
AR (1) AR246742A1 (fi)
AT (1) AT400333B (fi)
AU (1) AU630056B2 (fi)
BE (1) BE1004089A3 (fi)
CA (1) CA2032224C (fi)
CH (1) CH681624A5 (fi)
DE (1) DE4040685A1 (fi)
DK (1) DK171298B1 (fi)
DZ (1) DZ1471A1 (fi)
ES (1) ES2023607A6 (fi)
FI (1) FI906162A (fi)
FR (2) FR2656797B1 (fi)
GB (2) GB8928580D0 (fi)
GR (1) GR1000893B (fi)
HK (1) HK118093A (fi)
IE (1) IE65888B1 (fi)
IN (1) IN173969B (fi)
IT (1) IT1243412B (fi)
LU (1) LU87853A1 (fi)
MA (1) MA22013A1 (fi)
MY (1) MY104781A (fi)
NL (1) NL9002582A (fi)
NO (1) NO177146C (fi)
NZ (1) NZ236213A (fi)
OA (1) OA09475A (fi)
PT (1) PT96265B (fi)
SE (1) SE469383B (fi)
TN (1) TNSN90152A1 (fi)
ZA (1) ZA909663B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551623B1 (en) 1993-09-09 2003-04-22 Lorus Therapeutics Inc. Immunomodulating compositions from bile
CA2171281C (en) 1993-09-09 1998-12-29 Romeo Rang Immunomodulating compositions from bile
KR19980703088A (ko) 1995-03-16 1998-09-05 라카일레 지, 필리페 신규의 침전탄산칼슘 안료를 포함하는 잉크젯 기록지
US20040101569A1 (en) * 1996-05-16 2004-05-27 Lorus Therapeutics Inc. Immunomodulating compositions from bile
DE19711758C2 (de) * 1997-03-21 2003-06-18 Degussa Verfahren zur Herstellung von 1,3-Dioxanverbindungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732263A1 (de) * 1977-07-16 1979-02-01 Schuler Gmbh L Vorrichtung zum herstellen einer sicke am umfang eines hohlzylinders
DE2820893C2 (de) * 1978-05-12 1986-02-20 A. Nattermann & Cie GmbH, 5000 Köln Strukturanaloga von natürlichen Phospholipiden und Verfahren zur Herstellung dieser Verbindungen
US4737518A (en) * 1984-04-03 1988-04-12 Takeda Chemical Industries, Ltd. Lipid derivatives, their production and use
WO1989007099A1 (en) * 1988-02-05 1989-08-10 Schering Corporation 2,2-disubstituted glycerol and glycerol-like compounds, compositions and methods of use
JP2534893B2 (ja) * 1988-06-24 1996-09-18 日本ケミファ株式会社 新規なグリセリン誘導体およびその誘導体を含有する血小板凝集抑制剤
DE3906952A1 (de) * 1989-03-04 1990-09-06 Boehringer Mannheim Gmbh (3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel
GR1000688B (el) * 1989-12-22 1992-10-08 Sod Conseils Rech Applic Μεθοδος παρασκευης παραγωγων γλυκερινης.

Also Published As

Publication number Publication date
AR246742A1 (es) 1994-09-30
ES2023607A6 (es) 1992-01-16
CH681624A5 (fi) 1993-04-30
CA2032224C (en) 1996-12-10
GB8928580D0 (en) 1990-02-21
ATA259590A (de) 1995-04-15
IT9022438A1 (it) 1992-06-19
NO177146B (no) 1995-04-18
NL9002582A (nl) 1991-07-16
IN173969B (fi) 1994-08-13
MA22013A1 (fr) 1991-07-01
FR2656797B1 (fr) 1992-09-18
DK299590A (da) 1991-06-20
BE1004089A3 (fr) 1992-09-22
AU630056B2 (en) 1992-10-15
AT400333B (de) 1995-12-27
FI906162A0 (fi) 1990-12-14
NO905373D0 (no) 1990-12-12
SE9004039L (sv) 1991-06-20
GB2239239A (en) 1991-06-26
IE904567A1 (en) 1991-06-19
NO905373L (no) 1991-06-20
OA09475A (fr) 1992-11-15
TNSN90152A1 (fr) 1991-03-05
AU6814290A (en) 1991-06-27
FI906162A (fi) 1991-06-20
JPH04208256A (ja) 1992-07-29
KR910011759A (ko) 1991-08-07
IT1243412B (it) 1994-06-10
LU87853A1 (fr) 1991-05-07
DK299590D0 (da) 1990-12-18
GB2239239B (en) 1993-06-02
PT96265A (pt) 1991-09-30
HK118093A (en) 1993-11-12
IT9022438A0 (it) 1990-12-19
NO177146C (no) 1995-07-26
GR900100812A (en) 1992-05-12
SE9004039D0 (sv) 1990-12-18
CA2032224A1 (en) 1991-06-20
PT96265B (pt) 1998-06-30
FR2656307B1 (fr) 1992-09-18
SE469383B (sv) 1993-06-28
MY104781A (en) 1994-05-31
DE4040685A1 (de) 1991-06-20
FR2656307A1 (fr) 1991-06-28
US5118674A (en) 1992-06-02
IE65888B1 (en) 1995-11-29
GB9027421D0 (en) 1991-02-06
DZ1471A1 (fr) 2004-09-13
FR2656797A1 (fr) 1991-07-12
DK171298B1 (da) 1996-08-26
NZ236213A (en) 1993-03-26
GR1000893B (el) 1993-03-16

Similar Documents

Publication Publication Date Title
HU906006D0 (en) Process for the preparation of medical products
IL95946A0 (en) Preparation of tetrabromo-4,4'-alkylidenediphenols
CS202292A3 (en) Novel pyrrolopyrazines, process of their preparation and medicaments based thereon
ZA901765B (en) Derivatives of thieno-triazolo-diazepine,a preparation process of the same and therapeutic compositions containing them
ZA903305B (en) Thieno-triazolo-diazepine derivatives,a preparation process of the same and therapeutic compositions containing them
GB9025506D0 (en) A process for the preparation of a sauce for meat
AU635991B2 (en) Glycerol derivatives, a preparation process of the same and therapeutical compositions containing them
EP0431789A3 (en) Preparation process of polyimide
CS314191A3 (en) Novel derivative of 5h-benzodiazepine, process of its preparation and a pharmaceutical which it contains
ZA909663B (en) 3-(n-methyl-n-alkyl)-amino 2-methoxymethylene propan 1-ol derivatives,a preparation process of the same and therapeutical compositions containing them
ZA901764B (en) Sulfonyl derivatives of thieno-triazolo-diazepines,a preparation process of the same and therapeutic compositions containing them
EP0389110A3 (en) Process for the preparation of 2'-deoxy-5-trifluoromethyl-beta-uridine
HU902047D0 (en) Process for the preparation of pharmaceutical product
IL92465A0 (en) Process for the preparation of 4,4'-dibromodiphenylether
ZA906605B (en) N,n'-bis-1,3,5-triazin-6-ylpiperazines,and process for their preparation
ZA909026B (en) New selenophen derivatives,a preparation process of the same and therapeutical compositions containing them
ZA901718B (en) Sdk peptides,a preparation process of the same and therapeutic compositions containing them
GB2239242B (en) Process and the preparation of cyclohexanol derivatives
HU900036D0 (en) Process for preparation of 2,4-diamino-6-pyperidinyl-pyrimidin-3-n-oxide
IL94221A0 (en) Tetrahydroisoquino(2,1,c)(1,3)-benzodiazepines,a process for their preparation and their use as medicaments
IL95492A0 (en) Preparation of 3,7-dialkylxanthines
RO105695B1 (ro) -hidroxidifenilacetati de n-hidroxietilenpiridiniu-2,4,6-trisubstituiti perclorati si procedeu pentru prepararea lor
ZA9010003B (en) Glycerol derivatives,a preparation process of the same and therapeutical compositions containing them
CS8900898A2 (en) Preparation process of polyphenylenoxide
IL96638A0 (en) Alkylamino-and alkylaminoalkyl diarylketones,a process for their preparation and their use as medicaments